PIGF and fetal growth restriction: The two comprehensive results exacerbate placental ischemia/hypoxia and alter the release of sFLT-1 and PIGF from the placenta, which lead to the occurrence of maternal hypertension, proteinuria, and fetal growth restriction, i.e., PE.